Literature DB >> 32560088

Technological Approaches for Improving Vaccination Compliance and Coverage.

Céline Lemoine1,2, Aneesh Thakur3, Danina Krajišnik4, Romain Guyon5, Stephanie Longet6, Agnieszka Razim7, Sabina Górska7, Ivana Pantelić4, Tanja Ilić4, Ines Nikolić4, Ed C Lavelle8, Andrzej Gamian9, Snežana Savić4, Anita Milicic5.   

Abstract

Vaccination has been well recognised as a critically important tool in preventing infectious disease, yet incomplete immunisation coverage remains a major obstacle to achieving disease control and eradication. As medical products for global access, vaccines need to be safe, effective and inexpensive. In line with these goals, continuous improvements of vaccine delivery strategies are necessary to achieve the full potential of immunisation. Novel technologies related to vaccine delivery and route of administration, use of advanced adjuvants and controlled antigen release (single-dose immunisation) approaches are expected to contribute to improved coverage and patient compliance. This review discusses the application of micro- and nano-technologies in the alternative routes of vaccine administration (mucosal and cutaneous vaccination), oral vaccine delivery as well as vaccine encapsulation with the aim of controlled antigen release for single-dose vaccination.

Entities:  

Keywords:  adjuvants; compliance; cutaneous vaccination; microfluidics; mucosal vaccination; vaccine delivery

Year:  2020        PMID: 32560088     DOI: 10.3390/vaccines8020304

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  10 in total

Review 1.  A guide to oral vaccination: Highlighting electrospraying as a promising manufacturing technique toward a successful oral vaccine development.

Authors:  Ahmad M Aldossary; Chinedu S M Ekweremadu; Ifunanya M Offe; Haya A Alfassam; Sooyeon Han; Vivian C Onyali; Chukwuebuka H Ozoude; Emmanuel A Ayeni; Chinekwu S Nwagwu; Abdulrahman A Halwani; Nada H Almozain; Essam A Tawfik
Journal:  Saudi Pharm J       Date:  2022-03-15       Impact factor: 4.562

Review 2.  Immunogenicity and Reactogenicity in Q Fever Vaccine Development.

Authors:  Alycia P Fratzke; Erin J van Schaik; James E Samuel
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 3.  Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.

Authors:  Emrullah Korkmaz; Stephen C Balmert; Cara Donahue Carey; Geza Erdos; Louis D Falo
Journal:  Expert Opin Drug Deliv       Date:  2020-10-06       Impact factor: 8.129

Review 4.  Pathogen detection with electrochemical biosensors: Advantages, challenges and future perspectives.

Authors:  Hüseyin Oğuzhan Kaya; Arif E Cetin; Mostafa Azimzadeh; Seda Nur Topkaya
Journal:  J Electroanal Chem (Lausanne)       Date:  2021-01-09       Impact factor: 4.464

5.  Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World.

Authors:  Rossella Cianci; Laura Franza
Journal:  Vaccines (Basel)       Date:  2020-12-24

Review 6.  Microarray patches enable the development of skin-targeted vaccines against COVID-19.

Authors:  Emrullah Korkmaz; Stephen C Balmert; Tina L Sumpter; Cara Donahue Carey; Geza Erdos; Louis D Falo
Journal:  Adv Drug Deliv Rev       Date:  2021-02-02       Impact factor: 17.873

7.  A method for estimating the impact of new vaccine technologies on vaccination coverage rates.

Authors:  Ben Davis; Michael Krautmann; Pascale R Leroueil
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

8.  Starch-based NP act as antigen delivery systems without immunomodulating effect.

Authors:  François Fasquelle; Laurent Dubuquoy; Didier Betbeder
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

Review 9.  Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era.

Authors:  Patricia K Coyle; Anne Gocke; Megan Vignos; Scott D Newsome
Journal:  Adv Ther       Date:  2021-06-01       Impact factor: 3.845

10.  Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines.

Authors:  Aqel Albutti; Stephanie Longet; Craig P McEntee; Shauna Quinn; Alex Liddicoat; Cristiana Rîmniceanu; Nils Lycke; Lydia Lynch; Susanna Cardell; Ed C Lavelle
Journal:  Vaccines (Basel)       Date:  2021-06-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.